airsonett logo
Home UK SE DE US
US DISCLAIMER
The Airsonett website describes products and indications for European market customers.
In the US other regulatory aspects apply

News
Airsonett continues to focus on Clinical Research
Airsonett selected MedTech Company of the Year
Airsonett appointed new Founder Sponsor for EAACI
Airsonett contributes in SIS Project
Airsonett signs agreement with Russian partner


Board and Management
Company Profile
Press Releases & News
Vacancies
Image Bank
Contact Us
How to Find Us


Infection Control
Our Product
References
Order Spare Parts


What is Asthma?
How to Treat Asthma
Our Product
Indication
Clinical References
Order Filters
EAACI 2010
Airsonett is a research based medical technology company. Its TLA technology is used as a prophylactic treatment of allergic asthma;Protexo® and infection control in operating theatres; Opragon®.
Logon